When it comes to NVDA… “acceleration cycles” are the key

Expert options trader Graham Lindman has been working on a new way to tap into Nvidia’s options… By simply isolating outsized “acceleration cycles” within Nvidia stock (most investors don’t even know it exists)... And thanks to many months and late nights working out the kinks of the systems… They have finally found a way to target these cycles on Nvidia over and over again.

Use this link to see Nvidia Unchained right away!

Shaw Rietkerk Biography and Net Worth

COO of AdaptHealth

Shaw Rietkerk joined AdaptHealth Holdings in 2018. Mr. Rietkerk most recently served as Executive Vice President of Revenue Cycle Management at Brightree. Mr. Rietkerk has over two decades of healthcare service leadership experience, with an extensive background in revenue cycle management, operations, business process outsourcing, account management and process optimization. Prior to joining Brightree in 2015, Mr. Rietkerk was Senior Vice President, Worldwide Operations at M*Modal, a leading healthcare technology provider of advanced clinical documentation solutions.

What is Shaw Rietkerk's net worth?: The estimated net worth of Shaw Rietkerk is at least $2.05 million as of September 20th, 2024. Mr. Rietkerk owns 212,611 shares of AdaptHealth stock worth more than $2,049,570 as of November 17th. This net worth estimate does not reflect any other investments that Mr. Rietkerk may own. Learn More about Shaw Rietkerk's net worth.
How do I contact Shaw Rietkerk?: The corporate mailing address for Mr. Rietkerk and other AdaptHealth executives is 220 West Germantown Pike Suite 250, Plymouth Meeting PA, 19462. AdaptHealth can also be reached via phone at (610) 424-4515 and via email at [email protected]. Learn More on Shaw Rietkerk's contact information.
Has Shaw Rietkerk been buying or selling shares of AdaptHealth?: Shaw Rietkerk has not been actively trading shares of AdaptHealth over the course of the past ninety days. Most recently, Shaw Rietkerk sold 25,000 shares of the business's stock in a transaction on Friday, September 20th. The shares were sold at an average price of $11.24, for a transaction totalling $281,000.00. Following the completion of the sale, the chief operating officer now directly owns 212,611 shares of the company's stock, valued at $2,389,747.64. Learn More on Shaw Rietkerk's trading history.
Who are AdaptHealth's active insiders?: AdaptHealth's insider roster includes Jason Clemens (CFO), Stephen Griggs (CEO), Ronald Mcdaniel (Director), Frank Mullen (CAO), Alan Quasha (Director), Shaw Rietkerk (COO), and Dale Wolf (Director). Learn More on AdaptHealth's active insiders.
Are insiders buying or selling shares of AdaptHealth?: In the last year, insiders at the sold shares 7 times. They sold a total of 404,892 shares worth more than $4,373,675.18. The most recent insider tranaction occured on September, 20th when COO Shaw Rietkerk sold 25,000 shares worth more than $281,000.00. Insiders at AdaptHealth own 4.4% of the company. Learn More about insider trades at AdaptHealth.
Information on this page was last updated on 9/20/2024.

Shaw Rietkerk Insider Trading History at AdaptHealth

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
9/20/2024	Sell	25,000	$11.24	$281,000.00	212,611
11/10/2022	Sell	75,000	$22.52	$1,689,000.00	148,148
3/12/2021	Sell	55,000	$37.23	$2,047,650.00	250,053
12/7/2020	Sell	12,000	$34.91	$418,920.00	257,224

Shaw Rietkerk Buying and Selling Activity at AdaptHealth

AdaptHealth Company Overview

AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs. It also offers wheelchairs, hospital beds, oxygen concentrators, CPAP masks and related supplies, wound care supplies, diabetes management supplies, wheelchair cushion accessories, orthopedic bracing, breast pumps and supplies, walkers, commodes and canes, and nutritional and incontinence supplies. The company services beneficiaries of Medicare, Medicaid, and commercial insurance payors. The company is headquartered in Plymouth Meeting, Pennsylvania.

Today's Range

Now: $9.64

$9.52

$10.16

50 Day Range

MA: $10.61

$9.18

$11.49

2 Week Range

Now: $9.64

$6.43

$11.90

Volume

793,681 shs

Average Volume

1,032,435 shs

Market Capitalization

$1.30 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.11